VTIX Virtuix Holdings Inc. Insider Trading

CEO Goetgeluk Jan Roger sold 110,947 shares across 2 transactions for $575,925.62 ($5.19 blended avg); stock now at $4.03, -83.5% from 52-week high of $24.39.

Goetgeluk Jan Roger, Chief Executive Officer of Virtuix Holdings Inc., executed 2 separate sales totaling 110,947 shares for $575,925.62 on consecutive trading days (April 22–23, 2026), at prices of $5.96 and $4.58 respectively. The sales reduced his holdings by 2.6% to 4.20M shares. The current stock price of $4.03 has deteriorated significantly—down 83.5% from its 52-week high of $24.39 and off 43.6% in the past 30 days alone. Company fundamentals show deepening stress: the latest quarter recorded only $963.8K in revenue against a net loss of $-2.7M. The timing of these sales directly preceding a steep price decline, combined with mounting operational losses and collapsing revenue relative to burn, raises material questions about the business trajectory and the information asymmetries available to management at the transaction dates.

CEO Goetgeluk sold 137,553 shares (137.6K) for $948,872.28 on Apr 20–21 at $6.90–$6.96; stock now $5.26, down 78.4% from 52-week high.

Jan Roger Goetgeluk, Chief Executive Officer of Virtuix Holdings Inc., executed 2 separate sales totaling 137,553 shares for $948,872.28 across April 20–21, 2026, at a blended average price of $6.90. This represents a 3.1% reduction of his 4.31M post-transaction holdings. The timing is significant: the stock has since fallen to $5.26, a decline of 78.4% from its 52-week high of $24.39 and 34.2% over the prior 30 days, placing the sale price ($6.90) well above the current market price. Fundamentally, the company is unprofitable with net income of $-2.7M in the latest quarter against revenue of $963.8K, indicating severe operational stress. While the CEO's sale predates this recent sharp decline, the combination of a large insider reduction (137.6K shares), the subsequent severe price deterioration, and deteriorating unit economics warrants examination of whether the company's financial trajectory was diverging from market expectations at the time of the sale.